5ZIA
Crystal structure of human anti-tau antibody CBTAU-24.1 in complex with its phosphorylated tau peptide
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRL BEAMLINE BL12-2 |
| Synchrotron site | SSRL |
| Beamline | BL12-2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2015-04-12 |
| Detector | DECTRIS PILATUS3 S 6M |
| Wavelength(s) | 0.9795 |
| Spacegroup name | P 1 |
| Unit cell lengths | 86.353, 107.811, 107.931 |
| Unit cell angles | 62.16, 71.02, 90.77 |
Refinement procedure
| Resolution | 46.864 - 2.603 |
| R-factor | 0.2021 |
| Rwork | 0.200 |
| R-free | 0.24880 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4q9q |
| RMSD bond length | 0.013 |
| RMSD bond angle | 1.131 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 50.000 | 2.640 |
| High resolution limit [Å] | 2.600 | 2.600 |
| Rmerge | 0.125 | 0.526 |
| Rmeas | 0.182 | 0.637 |
| Rpim | 0.094 | 0.351 |
| Number of reflections | 88890 | 3914 |
| <I/σ(I)> | 8.3 | 1.7 |
| Completeness [%] | 91.1 | 79.3 |
| Redundancy | 3.4 | 2.6 |
| CC(1/2) | 0.900 | 0.650 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 50% (v/v) MPD, 0.2M (NH4)H2PO4, 0.1M Tris pH8.5 |






